The inflammatory response in Mycobacterium tuberculosis infection

Archivum Immunologiae et Therapiae Experimentalis

Volumn 48, Issue 6, 2000, Pages 513-519

  Toossi, Zahra ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Chemokine; Cytokine; Monocyte; Mycobacterium tuberculosis; Polymorphonuclear; Tuberculosis; Tumor necrosis factor

Indexed keywords

AUTACOID; CHEMOKINE; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

AIDS RELATED COMPLEX; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INFLAMMATION; LUNG TUBERCULOSIS; MACROPHAGE; METABOLISM; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; REVIEW; VIROLOGY;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CHEMOKINES; CYTOKINES; HIV-1; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHILS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034567602     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. ABOU-ZEID C., RATLIFF T. L., WIKER H. G., HARBOE M., BENNEDSEN J. and ROCK G. A. W. (1988): Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG. Infect. Immun., 56, 3046-3047.
2. ACTOR J. K., OLSEN M., JAGANNATH C. and HUNTER R. L. (1999): Relationship of survival, organism containment, and acute murine tuberculosis. J. Interferon Cytokine Res., 19, 1183-1193.
3. AUNG H., TOOSSI Z., WISNIESKI J. J., CULP L. A., PHILLIPS N. B., AVERILL L. E., DANIEL T. M. and ELLNER J. J. (1996): Induction expression of tumor necrosis factor alpha by the 30 kDa alpha antigen of Mycobacaterium tuberculosis synergism with fibronectin. J. Clin. Invest., 98, 1261-1268.
4. BARNES P. F., CHATTERJEE D., ABRAMS J. S., LU S., WANT E., YAMAMURA M., BRENNAN P. J. and MODIN R. L. (1992): Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J. Immunol., 149, 541-547.
5. BARNES P. F., LU S., ABRAMS J. S., WANG E., YAMAMURE M. and MODLIN R. L. (1993): Cytokine production at the site of the disease in human tuberculosis. Infect. Immun., 61, 3482-3489.
6. BOGDAN C., PAIK J., VODOVOTZ Y. and NATHAN C. (1992): Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor β and interleukin-10. J. Biol. Chem., 267, 2301-2308.
7. BOOM W. H. (1999): Gammadelta T cells and Mycobacterium tuberculosis. Microbes Infect., 1, 187-195.
8. BYRD T. F. (1997): Tumor necrosis factor (TNF) promotes growth of Mycobacterium tuberculosis in human monocytes. Iron-mediated growth suppression is correlated with decreased release of TNF. J. Clin. Invest., 99, 2528-2529.
9. CASATELLA A. M. (1999): Neutrophil-derived proteins: Selling cytokines by the pound. Adv. Immunol., 73, 369-494.
10. CHAN J. and KAUFMAN H. E. (1994): Immune mechanisms of protection. In BLOOM A. S. M. (ed.): Tuberculosis: pathogenesis, protection and control. Washington, DC, 389-415.
11. DAHL K. E., SHIRATSUCHI H., HAMILTON B. D., ELLNER J. J. and TOOSSI Z. (1996): Selective induction of TGF-β in human monocytes by lipoarabinomannan of M. tuberculosis. Infect. Immun., 64, 399-405.
12. DING A., NATHAN C. and SRIMAL S. (1990): Macrophage deactivating factor and TGF-β inhibit macrophage nitrogen oxide synthesis by IFN gamma. Immunology, 145, 940-945.
13. EHLERS S., BENINI J., KUTSCH S., ENDRES R., RIETSCHEL E. T. and PFEFFER K. (1999): Fatal granuloma necrosis without exacerbated mycobaterial growth in tumor necrosis factor receptor gene deficient mice intravenously infected with Mycobacterium avium. Infect. Immun., 67, 3571-3579.
14. ELLNER J. J. (1997): The human response in tuberculosis. J. Infect. Dis., 176, 1351-1359.
15. FENHALLS G., WONG A., BEZUIDENHOUT J., VAN HELDEN P., BARDIN P. and LUKEY P. T. (2000): In situ production of gamma interleukin-4 and tumor necrosis factor alpha mRNA in human lung tuberculosis granulomas. Infect. Immun., 68, 2827-2836.
16. FENTON M. J., VERMEULEN M. W., KIM S., BURDICK M., STRIETER R. M. and KORNFELD H. (1997): Induction of gamma Interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun., 65, 5149-5156.
17. FLYNN J. L., GOLDSTEIN M. M., CHAN J., TRIEBOLD K. J., PFEFFER K., LOWENSTEIN C. J., SCHREIBER R., MAK T. W. and BLOOM B. R. (1995): Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity, 2, 561-572.
18. FRATAZZI C., ARBEIT R. D., CARINI C., BALCEWICZ-SABLINSKA M. K., KEANE J., KORNFELD H. and REMOLD HG. (1999): Macrohpage apoptosis in mycobacterial infections. J. Leukoc. Biol., 66, 763-764.
19. FULTON S. A., MARTIN T. D., REDLINE R. W. and BOOM W. H. (2000): Pulmonary immune responses during primary Myco Calmette-Guerin bacillus infection in C57B16 mice. Am. J. Respir. Cell. Mol. Biol., 22, 333-343.
20. FULTON S. A., JOHNSEN J. M., WOLF S. F., SIEBERTH D. S. and BOOM W. H. (1996): Interleukin-12 production by human infected with Mycobacterium tuberculosis: role of phagocytosis. Infect. Immun., 64, 2523.
21. GARRAIT V., CADRANEL J., ESVANT H., HERRY I., MORINET P., MAYAUD C. and ISRAEL-BIET D. (1997): Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV. J. Immunol., 159, 2824-2830.
22. HIRSCH C. S., ELLNER J. J., RUSSELL D. G. and RICH E. A. (1994): Complement receptor-mediated uptake and tumor necrosis α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol., 152, 743-749.
23. HIRSCH C. S., TOOSSI Z., OTHIENO C., JOHNSON J. L., SCHWANDER S. K., ROBERTSON S., WALLIS R. S., EDMONDS K. A., MUGERWA R., PETERS P. and ELLNER J. J. (1999): Depressed T-cell interferon-gamma responses in pulmonary tuberculosis analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis., 180, 2069-2073.
24. HIRSCH C. S., YONEDA T., ELLNER J. J., AVERILL L. E. and TOOSSI Z. (1994): Enhancement of intracellular growth of M. tuberculosis in human monocytes by transforming growth factor beta. J. Infect. Dis., 170, 1229-1237.
25. HOWARD A. D. and ZWILLING B. S. (1998): Cytokine production by CD4 and CD8 T cells during the growth of Mycobacterium tuberculosis in mice. Clin. Exp. Immunol., 113, 443-449.
26. HUNTER S. W., GAYLORD B. E. and BRENNAN P. J. (1986): Structure and antigenicity of the phosophorylated lipopolysa antigens from the leprosy and tubercle bacilli. J. Biol. Chem., 261, 12345-12351.
27. HUYGEN K., VAN VOOREN J. P., TURNEER M., BOSMANS R., DIERCKX P. and DEBRUYN J. (1988): Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand. J. Immunol., 27, 187-194.
28. JACOBS M., BROWN N., ALLIE N. and RYFFEL B. (2000): Fatal Mycobacterium bovis BCG infection in TNF LT-alpha-deficient mice. Chest, 117, 103-109.
29. KASAHARA K., SATO I., OGURA K., TAKEUCHI H., KOBAYASHI K. and ADACHI M. (1998): Expression of chemokines and rapid cell death in human blood neutrophils by M. tuberculosis. J. Infect. Dis., 178, 127-137.
30. KASAHARI V. M., CHEN Y. Q., SU M. W., RAMIREZ F. and UITTO J. (1990): Tumor necrosis factor α and interferon γ suppress the activation of human type I collagen gene expression by transforming growth factor β 1. J. Clin. Invest., 86, 1489-1494.
31. KEMP K., HVIID L., KHARAZMI A. and KEMP M. (1997): Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major. Scand. J. Immunol., 46, 495-499.
32. KIM S. J., ANGEL P., LAFYATIS R. and ROBERTS A. B. (1990): Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex. Mol. Cell. Biol., 10, 1492-1495.
33. KINDLER V., SAPPINO A. P., GRAU G. E., PIGUER P. F. and VASSALLI P. (1989): The inducing role of tumor necrosis factor in the development of bacterial granulomas during BCG infection. Cell, 56, 731-740.
34. LAWN S. D., SHATTOCK R. J., ACHEAMPONG J. W., LAL R. B., FOLKS T. M., GRIFFIN G. E. and BUTERA S. T. (1999): Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans. AIDS, 13, 2231-2237.
35. LIN Y., ZHANG H., GONG J. and BARNES P. F. (1996): Absence of a prominent TH2 cytokine response in human tuberculosis. Infect. Immun., 64, 1351-1356.
36. MAY M. and SPAGNUOLO P. J. (1987): Evidence for activation of the respiratory burst in the interaction of human neutrophils with M. tuberculosis. Infect. Immun., 55, 2304-2307.
37. MUSTAFA T., PHYU S., NILSEN R., JONSSON R. and BJUNE G. (2000): In situ expression of cytokine and cellular phenotypes in mice with slowly progressive primary tuberculosis. Scand. J. Immunol., 51, 548-556.
38. MUTHUSWAMY P., HU Y. C., CARASSO B., ANTONIO M. and DANDAMUDI N. (1995): Prednisone as adjunctive therapy in the management of pulmonary tuberculosis report of 12 cases and review of the literature. Chest, 107, 1621-1630.
39. NORTH R. J. (1995): M. tuberculosis strikingly more virulent for mice when given via the respiratory than via the intravenous route. J. Infect. Dis., 172, 1550-1553.
40. OPPENHEIM J. J., ZACHARIE C. O. C., MOKAIDA N. and MATSAMUSHIMA K. (1991): Properties of the novel pro-inflamma "intercine" cytokine family. Annu. Rev. Immunol., 9, 617-648.
41. ORME I. M. and COOPER A. M. (1999): Cytokine/chemokine cascades in immunity to tuberculosis. Immunol. Today, 20, 307-312.
42. OTHIENO C., HIRSCH C. S., HAMILTON B. D., WILKINSON K., ELLNER J. J. and TOOSSI Z. (1999): Interaction of M. tuberculosis-induced transforming growth factor β1 and interleukin 10. Infect. Immun., 67, 5730-5735.
43. RHOADES E. R., FRANK A. A. and ORME I. M. (1997): Progresion of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis., 78, 57-66.
44. RICH E. A., TORRES M., SADA E., FINEGAN C. K., HAMILTON B. D. and TOOSSI Z. (1997): Mycobacterium tuberculosis-stimulated expression of inducible nitric oxide synthase and production of nitric oxide by human alveolar macrophages. Tuber. Lung Dis., 78, 247-255.
45. RIEDEL D. D. and KAUFMANN S. H. (1997): Chemokine secretion by human polymorphonuclear granulocytes after stimulation with M. tuberculosis and lipoarabinomannan. Infect. Immun., 65, 4620-4523.
46. ROLLINS B. J. (1997): Chemokines. Blood, 90, 909-928.
47. ROOK G. A. W. and HERNANDEZ-PANDO R. (1996): The pathogenesis of tuberculosis. Annu. Rev. Microbiol., 50, 259-284.
48. SADEK M. I., SADA E., TOOSSI Z., SCHWANDER S. K. and RICH E. A. (1997): Chemokines induced by infection of mono phagocytes with M. tuberculosis and in the lungs during active pulmonary tuberculosis. Tuber. Lung Dis., 78, 247-255.
49. SCHWANDER S. K., SADA E., TORRES M., ESCOBEDO D., SIERRA J. G. and ALT RICH E. A. (1996): T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J. Infect. Dis., 173, 1267-1272.
50. SCHWANDER S. K., TORRES M., CARRANZA C., ESCOBEDO D., TARY-LEHMANN M., ANDERSON P., TOOSSI Z., ELLNER J. J., RICH E. A. and SADA E. (2000): Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J. Immunol., 165, 1479-1485.
51. SENDEROVITZ T. and VISKUM K. (1994): Corticosteroids and tuberculosis. Res. Med., 88, 561-569.
52. SILVER R. F., LI Q and ELLNER J. J. (1998): Expression of virulence of Mycobacerium tuberculosis with human monocytes: virulence correlates with intracellular growth and induction of tumor necrosis factor alpha but not with evasion of lymphocyte-dependent monocyte effector functions. Infect. Immun., 66, 1190-1199.
53. SMITH D. W., WIEGESHAUS E. H., NAVALKAR R. and GROVER A. A. (1966): Host-parasite relationships in experimental airborne tuberculosis. I. Preliminary studies in BCG-vaccinated and nonvaccinated animals. J. Bacteriol., 91, 718-724.
54. SNIDER D. E., RAVIGLIONE M. and KOCHI A. (1994): Global burden of tuberculosis. In BLOOM A. S. M. (ed.): Tuberculosis: pathogenesis, protection and control. Washington DC., 3-11.
55. SOLIS-HERRUZO J. A., BRENNER D. A. and CHOJKIER M. (1998): Tumor necrosis factor α inhibits collagen gene transcription and collagen synthesis in cultured human fibroblasts. J. Biol. Chem., 163, 5841-5847.
56. SPORN M. B., ROBERTS A. M., WAKEFIELD L. M. and ASSOIAN R. K. (1986): Transforming growth factor β biological function and chemical structure. Science, 233, 532-535.
57. TAVARES J. L., WANGOO A., DILWORTH P., MARSHALL B., KOTECHA S. and SHAW R. J. (1997): Thalidomide reduces tumor necrosis factor α alpha production by human alveolar macrophages. Respir. Med., 91, 31-39.
58. TOOSSI Z. (1996): Cytokine circuits in tuberculosis. Infect. Agents Dis., 5, 98-107.
59. TOOSSI Z., GOGATE P., SHIRATSUCHI H., YOUNG T. and ELLNER J. J. (1995): Enhanced production of transforming growth factor β (TGFβ) by blood monocytes from patients with active tuberculosis and presence of TGFβ in tuberculosis granulomatous lung lesions. J. Immunol., 154, 465-473.
60. TOOSSI Z., HIRSCH C. S., HAMILTON B. D., KNUTH C. K., FRIEDLANDER M. A. and RICH E. A. (1996): Decreased production of transforming growth factor β1 (TGFβ1) in human alveolar macrophages. J. Immunol., 156, 3461-3468.
61. TOOSSI Z., XIA L. and SALVEKAR A. (1999): Transcriptional activities of human immunodeficiency virus (HIV) by Mycobacterium tuberculosis in human monocytes. Clin. Exp. Immunol., 117, 324-330.
62. TORRES M., HERRERA T., VILLAREAL H. and SADA E. (1998): Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to 30 kD antigen of Mycobacterium tuberculosis. Infect. Immun., 66, 176-180.
63. TRAMONTANA J. M., UTAIPAT U., MOLLY A., AKARASEWI P., BURROUGHS M., MAKONKAWKEYPOON S., JOHNSON B., KLAUSNER J. D., ROM W. and KAPLAN G. (1995): Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol. Med., 1, 384-397.
64. TSAO T. C., HONG J., HUANG C., YANG P., LIAO S. K. and CHANG K. S. (1999): Increased TNF-alpha, IL-1 beta and IL-6 levels in bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients active pulmonary tuberculosis. Tuber. Lung Dis., 79, 279-285.
65. VALONE S. E., RICH E. A., WALLIS R. S. and ELLNER J. J. (1988): Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect. Immun., 56, 3313-3333.
66. VANHAM G., EDMONDS K. E., QING L., HOM D., TOOSSI Z., JONESS B., DALEY C., HUEBNER R., KESTENS L., GIGASE P. and ELLNER J. J. (1996): Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin. Exp. Immunol., 103, 30-34.
67. VICENZI E., BISWAS P., MENGOZZI M. and POLI G. (1997): Role of pro-inflammatory cytokines and b-chemokines in controlling HIV replication. J. Leukoc. Biol., 62, 34-40.
68. WAHL S. M., ALLEN J. B., WEEKS B. S., WONG H. L. and KLOTMAN P. E. (1993): Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA, 90, 4577-4581.
69. WALLIS R. S., FUJIWARA H. and ELLNER J. J. (1996): Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J. Immunol., 136, 193-196.
70. WALLIS C. C., NSUBUGA P., WHALEN C. C., MUGERWA R. D., OKWERA A., OETTE D., JACKSON J. L., JOHNSON J. J. and ELLNER J. J. (1996): Pentoxifylline therapy in human immunodeficiency virus-serpositive persons with tuberculosis: a randomized controlled trial. J. Infect. Dis., 174, 727-733.
71. WALLIS R. S., PARANJAPE R. and PHILLIPS M. (1993): Identification by two-dimensional gel electrophoresis of a 58-kilodalton tumor necrosis factor-inducing protein of Mycobacterium tuberculosis. Infect. Immun., 61, 627-632.
72. WHALEN C., HORSBURGH C. R., HOM D., LAHART C., SIMBERKOFF M. and ELLNER J. J. (1995): Accelerated course of human immunodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med., 151, 129-135.
73. ZABEL A. and ULRICH SCHADE F. (1993): Inhibition of endogenous TNF formation by Pentoxifylline. Immunobiology, 187, 447-463.
74. ZHANG Y., BROSER M., COHEN H., BODKIN M., LAW K.. REIBMAN J. and ROM W. N. (1995): Enhanced interleukin and gene expression in macrophage after exposure to Mycobacterium tuberculosis and its comp. J. Clin. Invest., 95, 586-592.
75. ZHU W., DOWNEY J. S., GU J., DI PADOVA F., GRAM H. and HAN J. (2000): Regulation of TNF expression by multiple mitogen-activated protein kinase pathways. J. Immunol., 164, 6349-6358.
76. ZUGMAIER G., PAIK S., WILDING G., KNABBE C., BANO M., LUPU R., DESCHAUER B., SIMPSON S., DICKSON R. B. and LIPPMAN M. (1991): Transforming growth factor β 1 induces cachexia and systemic fibrosis without an antitumor effect in nude mice. Cancer Res., 51, 3590-3594.